Publicaciones en las que colabora con MARÍA DOLORES GUTIÉRREZ LÓPEZ (18)

2022

  1. Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61-8048 after chronic intermittent ethanol in mice

    British Journal of Pharmacology, Vol. 179, Núm. 14, pp. 3711-3726

2021

  1. Addiction and the kynurenine pathway: A new dancing couple?

    Pharmacology and Therapeutics, Vol. 223

  2. Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor

    Neuropharmacology, Vol. 187

2019

  1. Changes in brain kynurenine levels via gut microbiota and gut-barrier disruption induced by chronic ethanol exposure in mice

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 33, Núm. 11, pp. 12900-12914

2018

  1. Increasing kynurenine brain levels reduces ethanol consumption in mice by inhibiting dopamine release in nucleus accumbens

    Neuropharmacology, Vol. 135, pp. 581-591

2017

  1. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus

    Neuropharmacology, Vol. 118, pp. 157-166

  2. Disruption of blood–brain barrier integrity in postmortem alcoholic brain: preclinical evidence of TLR4 involvement from a binge-like drinking model

    Addiction Biology, Vol. 22, Núm. 4, pp. 1103-1116

2014

  1. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X7 receptors

    International Journal of Neuropsychopharmacology, Vol. 17, Núm. 8, pp. 1243-1255

  2. The JNK inhibitor, SP600125, potentiates the glial response and cell death induced by methamphetamine in the mouse striatum

    International Journal of Neuropsychopharmacology, Vol. 17, Núm. 2, pp. 235-246

2013

  1. A study on the effect of JNK inhibitor, SP600125, on the disruption of blood-brain barrier induced by methamphetamine

    Neurobiology of Disease, Vol. 50, Núm. 1, pp. 49-58

  2. Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: Implications for the pathogenesis of free radical-induced neurodegenerative disorders

    Psychopharmacology, Vol. 230, Núm. 1, pp. 125-135

  3. Implicación de la molécula de adhesión ALCAM en el daño cerebral. Modelo de daño neuronal mediante la administración de MDMA/éxtasis en rata

    Trauma (Spain), Vol. 24, Núm. 2, pp. 101-108

2011

  1. Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): Regulation by CB2 receptors and implications for neurotoxicity

    Journal of Neuroinflammation, Vol. 8

  2. Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA

    Journal of Neuroinflammation, Vol. 8

2010

  1. Administration of neurotoxic doses of MDMA reduces sensitivity to ethanol and increases GAT-1 immunoreactivity in mice striatum

    Psychopharmacology, Vol. 207, Núm. 4, pp. 671-679

  2. Evidence that MDMA ('ecstasy') increases cannabinoid CB2 receptor expression in microglial cells: Role in the neuroinflammatory response in rat brain

    Journal of Neurochemistry, Vol. 113, Núm. 1, pp. 67-78

  3. Involvement of 2-arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine

    British Journal of Pharmacology, Vol. 160, Núm. 3, pp. 772-783

  4. Sex-dependent maternal deprivation effects on brain monoamine content in adolescent rats

    Neuroscience Letters, Vol. 479, Núm. 2, pp. 112-117